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Background: Influenza vaccination is an important public health intervention for controlling disease burden, but
coverage rates are still low also in risk groups. In order to identify non-vaccinating subgroups, deprivation and
socio-economic indices, i.e. measures used to synthetically describe people’s socio-economic status while taking
into account several dimensions, may be used. We aimed to synthetize evidence from studies investigating asso-
ciation between deprivation/socio-economic indices and influenza vaccination coverage in population at risk—
persons 65 years of age, individuals with comorbidities, pregnant women and health-care workers.Methods:We
searched PubMed, ISI WoS, CINAHL and Scopus to identify observational studies published up to October 10th
2017 in English or Italian. Studies reporting quantitative estimates of the association between deprivation/socio-
economic indices and influenza vaccination coverage in populations at risk were included. Results: A total of 1474
articles were identified and 12 were eventually included in the final review. Studies were mostly cross-sectional,
performed in European countries, from 2004 to 2017. Seven studies focussed on deprivation and five on socio-
economic indices. Studies on deprivation indices and vaccination coverage showed that people from the most
deprived areas had lower coverage. Regarding socio-economic condition, results were contrasting, even though it
may also be concluded that people from lower groups have lower vaccination coverage. Conclusions: Our work
supports the possibility to identify people likely to have lower influenza vaccination coverage based on depriv-
ation/socio-economic indices. Efforts should be performed in order to further strengthen robustness, transferabil-
ity and suitability of these indices in addressing public health problems.
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Introduction
Seasonal influenza virus circulates worldwide and can affect peoplein any age group. Depending of the local climate, seasonal
influenza epidemics occur mostly during the wintertime while in
the tropical regions seasonality is less obvious and can occur at
any time of the year. Even though most people will recover
completely without any sequelae, the influenza can cause some
serious complications, invalidity and even death.1 Severe infection
and influenza-related complications typically occur in pregnant
women, children <59 months of life, individuals with chronic
medical conditions (such as chronic cardiac, pulmonary, renal,
metabolic, neuro-developmental, liver or haematologic diseases),
immunocompromised persons and older adults (aged 65 years).2
According to the current statistics, from 291 000 to 646 000 people
worldwide die from seasonal influenza-related respiratory illnesses
each year. The highest mortality rates were estimated among people
aged 75 years or older (51.3–99.4 per 100 000 individuals).3 In the
European region, the European Center for Disease Prevention and
Control (ECDC) estimates 44 000 people die every year because of
respiratory diseases associated with seasonal influenza.4 According to
annual surveys funded by the ECDC and World Health Organization
(WHO), even though 34 000 (over 75%) of these deaths in Europe
are among people aged 65 years or over, the vaccine uptake remains
low in this group.4
Immunization against influenza is an important tool for reducing
morbidity and mortality among high-risk patients, including the
elderly. Influenza vaccination in population 65 years decreases
the incidence of disease and hospitalization as well as the risk of
influenza-related complications and death.5,6 The WHO
recommends annual influenza vaccinations for specific risk groups,
i.e. elderly individuals (65 years old), population with chronic
diseases, pregnant women, children from 6 months to 5 years old
and health-care workers (HCWs).7 In fact, the HCWs are at risk
for acquiring influenza virus infection due to the increased
exposure to patients and, at the same time, they are even
considered a potential source of transmission.8 Still, recommenda-
tions vary from country to country, even from one region to another
and go from universal recommendations across the recommenda-
tions for specific risk groups to no recommendation at all.8
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Although, during the eight seasons covered in the VENICE report
(2007–08 to 2014–15), an increasing number of Member States rec-
ommended the vaccine to high-risk groups as identified by WHO
and ECDC.9 Nevertheless, despite these efforts, the influenza vaccin-
ation coverage is unsatisfactory in many countries as reported in the
VENICE surveys: vaccination coverage ranged from 1.0 to 76.3%
(median 47.6%) for older adults, from 28.7 to 78.7% (median
44.4%) for those with chronic medical conditions, from 0.3 to
58.2% (median 22.6%) for pregnant women and from 5.7 to
54.4% (median 26.9%) for HCWs.9
Inequalities in vaccine uptake amongst individuals belonging to
different risk groups could be related to several socio-economic
factors and determining their role could enable planning targeted
interventions and adjustment of vaccination programmes in order to
improve the vaccine uptake.10,11 Socio-economic factors affecting
influenza vaccine uptake may vary across different risk groups and
also with the type of vaccine (seasonal or pandemic).11–13 A recent
systematic review and meta-analysis14 on the effect of several single
factors on vaccine uptake amongst individuals aged 60 years of age
in Europe concluded that living alone, being unmarried or an
immigrant and residing in a deprived area were associated with
lower vaccine intake. On the contrary, no consistent effect was
observed for education, social class and urban residence.
The use of socio-economic deprivation indices has been proposed
to identify and evaluate the relationship between socio-economic
conditions and health.15,16 In fact, deprivation indices in respect to
single factors have the advantage of describing socio-economic
status (SES) taking into account several dimensions, while
remaining synthetic and easily interpretable.17 These indices,
producing a geographical description of the population’s health
conditions and approximating the individual’s SES according to
the area of residence, could be useful to identify populations at
higher risk.15,16 In fact, SES is considered one of the main social
determinants of the health status and also of individuals’ ability to
follow preventive and treatment indications11 but few studies have
specifically focussed on the role played by deprivation indices in
determining vaccine uptake.18–22
Nonetheless, since the role of deprivation indices is becoming
increasingly relevant to develop targeted interventions, we aimed
to systematically assess and quantify the association between these
indices and influenza vaccination uptake amongst individuals
considered at high-risk, through a systematic review of available
literature on the topic.
Methods
Literature search
Identification of the potentially eligible studies was carried out in
line with the recommendations from the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) statement23
and through a multi-engine literature search of PubMed, ISI Web
of Science (WoS), CINAHL and Scopus databases. Each database
was systematically screened using a specific search query as a com-
bination of subject headings and text words, to search for studies
published up to October 10th 2017, in English or Italian. The
following search query was used to retrieve the potentially eligible
studies from PubMed: ((vaccin OR immuni OR prevent) AND
(coverage OR campaign OR adherence OR program) AND influenza
AND (Index of deprivation OR deprivation index OR socio-economic
status OR socio-economic status OR SES OR deprivation status OR
((socio-economic OR socio-economic OR socio-demographic OR socio-
demographic AND (indicator OR indicators OR determinant OR de-
terminants)) OR socio-economic position OR socio-economic position
OR SEP OR Social determinants of health)). The search query was
appropriately modified for screening the other databases (detailed
search queries are available upon request). Cross-linking of the
studies retrieved from different databases was performed in order
to remove duplicates. Bibliographies of eligible studies were
eventually hand-searched to check for additional studies.
Study selection
We considered articles that provided evidence on the association
between the deprivation indices or SES and influenza vaccine
coverage (pandemic or seasonal) in populations at high-risk. We
defined the population of interest as persons at higher risk for
influenza infection or its complications, namely persons 65 years
of age, individuals with documented comorbidities, persons with
disabilities, pregnant women and HCWs. Observational studies
including cross-sectional, ecological, case-control or cohort studies
from any country and study setting (community or nursing home/
hospital) were considered eligible. Studies that were conducted only
on healthy children or adults exploring single social determinants
(i.e. educational level, marital status) or other vaccine-preventable
disease vaccination were considered not eligible. We further
excluded cost-effectiveness and economic analyses. Finally, reviews,
meta-analyses, letters and commentaries were disregarded because
they did not report original data. We only included studies provided
with full-text articles.
Three couples of reviewers (M.C. and F.F.; S.L. and C.d.W.; G.M.
and V.V.) independently screened titles and abstracts of the retrieved
articles in order to select the eligible ones. Full texts of the potentially
eligible articles were subsequently retrieved and further assessed
according to the reported criteria. A valid justification for
exclusion was reported and any disagreements were resolved
through consensus for the final inclusion.
Data extraction and synthesis
Three reviewers (V.V., M.C. and C.d.W.) independently conducted
the data extraction from each article and any difference in opinion
was resolved through discussion to reach consensus or in consult-
ation with other co-authors. Data on the first author’s name, year of
publication, country, flu season and type of vaccination, study
design, setting, study population, data source used for the ascertain-
ment of vaccination status, influenza vaccination policy, compos-
ition of the deprivation index or SES, vaccine coverage, effect
estimates (in terms of relative risks or odds ratios) with 95% CI
and variables used for adjusting effect estimates were extracted. In
case of multiple articles describing the same study population, we
only included the most recent one. When there were missing or
incomplete data, authors of the selected articles were contacted to
obtain additional information. Because of the significant heterogen-
eity among the studies, in particular with respect to variables used to
develop the deprivation indices and SES, we were not able to
perform a quantitative pooling of data through meta-analysis and
thus all the information from the included studies was summarized
and described through a narrative synthesis.
Quality assessment
In order to assess the methodological quality of the included studies
we used the Newcastle-Ottawa Quality Assessment Scale (NOS).24
Three reviewers (S.L., F.F. and G.M.) independently evaluated each
study and disagreements were resolved through discussion or in
consultation with other co-authors until the consensus was
achieved. The NOS uses a ‘star system’ and assigns up to a
maximum of nine points in three perspectives: the selection of the
study groups (four points); the comparability of the groups (two
points) and the ascertainment of exposure or outcome of interest for
case-control or cohort studies (three points), respectively. Detailed
instructions for using the NOS are provided elsewhere.25 For the
cross-sectional studies included in our review, we used the already
adapted NOS by Herzog et al.26 The latter was also used to assess
ecological studies. We appraised the quality of the eligible studies
without excluding them a priori based on the result since valuable
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conclusions, grounded in data, might be achieved even in the studies
with low methodological quality.
Results
Search results and study characteristics
The initial search of PubMed, ISI WoS, Scopus and CINAHL online
databases identified a total number of 1474 studies. After removing
the duplicates and reading the abstracts and titles, 124 full texts
articles were selected to be assessed for further eligibility. By not
fulfilling the inclusion criteria, 116 full texts were excluded,
leaving 8 eligible studies to be finally included in the review. By
closely inspecting the references of the included studies, we addition-
ally identified 4 studies to be added, thus concluding a selection
process with a final number of 12 studies included.27–38 Detailed
process of literature search and study selection is presented in
figure 1.
Our search covered a wide time interval, including studies
published from 200430 to the most recent one from 2017.37
Eligible studies were conducted in high-income European
countries, mostly in the UK,27,29–31,35,38 France,37 Germany36 and
in Israel28,32 except for one study from Colombia33 and one
from Canada.34 Most of the studies used the cross-sectional
survey27–31,33,36–38 while two were ecologic studies34,35 and one
study was case-control.32 The study setting was represented by
community in all studies, except one study that used the hospital
setting.32 Sample size varied greatly across the included studies, with
the smallest sample of 806 participants32 conducted in a hospital
setting on patients with malignancies; up to the largest of more
than 2.8 million individuals aged  65 years conducted in the UK.35
Most of the studies focussed on participants 60 years old,27–
31,33,35 on participants belonging to the clinical-risk groups,32,38
and special target groups (pregnant women, people with disability,
HCWs).34,36,37 The most common method for ascertaining partici-
pants’ vaccination status was by using records extracted from the
national/regional vaccination databases;27,29,34,35,37 from the general
practitioner’s records30–32,38 and according to self-reporting through
interviews or telephone-survey.33,36 One study did not report the
data source used for ascertaining the participants’ vaccination
status.28 Influenza immunization was recommended and free of
charge in all of the countries/regions for the individuals included
in the studies, except for the population from the paper of Schwartz
et al.28 where flu vaccination at no or low cost for individuals having
Figure 1 Flowchart depicting literature search and study selection process
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universal health insurance was suggested. Two studies27,32 did not
report specifications about vaccination policies for the included
population. Detailed characteristics of the included studies are
summarized and presented in the table 1.
Quality assessment
Overall, studies showed good quality, with two studies scoring
maximum points27,34 (Supplementary table S1). Studies
demonstrated the highest scores in the exposure/outcome domain
section, while the lowest points were given when evaluating the
control of the confounding factors in the comparability domain.
The confounding bias mostly resulted from the lack of adjustment
in the multivariable models used.
Vaccine uptake
Ten studies ascertained the uptake of seasonal influenza vaccination
(SIV),27–33,35–37 with one focussing only on pandemic influenza vac-
cination (PIV),34 and one on both.38 Research expanded from 1997/
98 influenza season30 up to the season 2012/13.33 Within each
included study the vaccine uptake was reported separately for a
variety of different interest groups. The highest SIV uptake was
recorded by Norbury et al.29 in the group of people aged
65 years and in patients with one or more chronic disease
(mean =71.1%; SD =2.9) for the influenza season 2006/07, while
the lowest vaccination coverage (mean =23.7%; SD =4.1) was
documented in a group of people aged 18–65 years with disabilities
for 2007/08 season by Bocquier et al.37 Regarding the PIV, the mean
vaccine uptake was 39.4% (SD =3.0) for the pandemic season 2009/
10 in the population belonging to the clinical-risk group38 and
49.4%, 38.9% and 66.8% in pregnant women, chronically ill
people <65 years of age and HCWs, respectively.34 Vaccine uptake
in different risk groups and for the specific deprivation/SES groups
are presented in table 2.
Deprivation indices and SES
Seven studies27,29–31,34,35,38 investigated the association of depriv-
ation indices with the influenza vaccine uptake (SIV alone n = 5,
PIV and SIV n = 1, and PIV alone n = 1), and five studies28,32,33,36,37
used the socio-economic strata to explore the same associations with
the SIV uptake. Three UK studies used the Carstairs deprivation
index,29–31 two UK studies used the Townsend deprivation
index,35,38 while the remaining UK study used the Index of
Multiple Deprivation (IMD) 2007.27 The only study that used the
material and social deprivation was conducted in Canada.34
Variables included in the composition of SES varied across the
studies.28,32,33,36,37 Details are summarized and presented in table 1.
Six studies28,29,32–34,36 used the OR as a measure of association,
five27,30,31,35,37 used the RR, while the remaining study38 used the
incidence rate ratio. Vaccine uptake was negatively associated with
deprivation of the area where people were living. In the most
deprived areas, subjects were less likely to be vaccinated than those
from affluent areas, in people belonging to the clinical-risk group
[asthma, chronic obstructive pulmonary disease (COPD), chronic
heart disease, chronic kidney disease, diabetes, chronic liver disease,
stroke/transient ischaemic attack, central nervous system degener-
ation and immunosuppression], pregnant women, HCWs34,38 and
people 65 years old27,29–31,35 (table 2). These associations were
reported across the included studies regardless of the vaccine type
(SIV or PIV), measure of effect or different deprivation groups used
as references (most deprived or least deprived category). A less
obvious result was reported among the studies that investigated
SES of the interest groups and their vaccine uptake. Three studies
reported that the individuals from high-risk groups (in particular
cancer patients and people with disability)32,37 and those 65 years
of age28 belonging to the highest SES category had a higher prob-
ability of SIV uptake than those in the lowest SES category. On the
other hand, Gutierrez et al.33 concluded that persons 60 years of
age from the upper class had lower odds for influenza vaccination
(OR = 0.16; 95% CI: 0.08–0.30), compared to those from lower
class. Bo¨hmer et al.36 also confirmed that the chance of SIV
uptake was lower in persons with high SES when compared with
persons with low one (OR = 0.74; 95% CI: 0.66–0.84).
Discussion
The results of our systematic review show that people belonging to
the most deprived areas have lower influenza vaccination coverage.
This evidence is consistently reported by studies included in this
review that considered deprivation indices,27,29–31,34,35,38 even
though it is noteworthy to observe that they were mainly
performed in the UK. Regarding the socio-economic condition,
threes studies28,32,37 reported overlapping results with respect to
those addressing deprivation indices and two33,36 reported a lower
vaccination uptake in people belonging to the richest groups.
Nevertheless, these two were the only studies that relied on self-
reported vaccination status and did not adjust the analyses for
other factors. These two aspects may undermine the robustness of
their results and could suggest that overall, the evidence is more in
favour of a higher vaccination uptake in wealthier people, independ-
ently of the index considered in the analyses.
Inequalities in health among groups belonging to different socio-
economic conditions constitute one of the main challenges for
public health,39 as mortality and poorer self-assessments of health
are substantially higher in the lower socio-economic groups.40
Strong evidence from many studies supports an association
between low SES and different health conditions. A systematic
review and meta-analysis assessed the difference in HbA1c levels
among people with type 2 diabetes of different SES, showing
higher HbA1c levels in people of low SES as compared to people
of high SES.41 Empana et al. investigated deprivation at the
individual level using a multivariable index covering socio-
economic and psychosocial dimensions demonstrating an inverse
relationship between increasing level of deprivation and ideal car-
diovascular health as defined by the American Heart Association.42
Another recent study showed that patients from the lowest SES had a
first stroke earlier than those from the highest, showed more
commonly pre-stroke disability and diabetes, and had higher
adjusted risk of 1-year mortality.43
Socio-economic deprivation was shown to influence mortality
after colorectal surgery too, with higher mortality in more
deprived socio-economic groups, both in the short- and in the
long-term period.44 Also, the influenza-related hospitalization rates
were found higher among persons residing in census tracts including
more people living below the poverty level.45
The reasons why deprivation influences health status and
outcomes may be found also in its relationship with the distribution
of health determinants. In fact, an international comparative study
conducted by Mackenbach et al. among 22 European countries
showed that although inequalities in health associated with SES
are present everywhere, their magnitude was highly variable, par-
ticularly for inequalities in mortality and from selected causes,
suggesting that variations may be attributable to socio-economic
differences in lifestyles and access to health-care.46 With this
respect, influenza vaccination uptake can be considered a health-
inequality indicator and, therefore, persons living in poorer areas
should be targeted for enhanced influenza vaccination outreach.47
The results of our systematic review, together with the evidence
from the international literature, suggest that decision makers
should consider the full range of determinants that may influence
health outcomes when designing public health interventions and
should work toward mitigating social and health shocks to protect
people already experiencing frail socio-economic condition. With
this respect, the use of deprivation indices for identifying frail
4 European Journal of Public Health
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people could be useful, even though they show general problematic
aspects that should be mentioned. Firstly, deprivation indices are
useful measures to analyze health inequalities but they are con-
structed by several methods,48–51 therefore it can be difficult to
choose a valid and reliable index for studying different
phenomena, even if they have been proven to be useful in identifying
patterns of inequalities in health outcomes.48–55 The different used
methods answer to the different ways of empirically defining depriv-
ation, namely ‘any disadvantage of an individual or human group,
related to the community or society to which the individual or
human group belongs, and these disadvantages can be of social or
material nature’.51,52 As a consequence, measuring deprivation
requires the identification of two main issues: which indicators
will be used to construct a deprivation index and how to combine
them. The criteria for choosing different indicators that compose
deprivation indices can vary according to the theoretical approach
that foreshadow the methodological development of the index.56–58
Two main approaches can be described: a top-down and a
bottom-up approach.57–59 In the top-down approach, the variables
composing the index are chosen according to the theoretical
definition of deprivation and, in some cases, according to the
specific aim at the basis of the index computing without any early
consideration about statistical issues. In the bottom-up approach a
wide group of variables, usually covering all or the main aspects of
the demographic and socio-economic characteristics of the study
population, are considered and then reduced to a more
manageable number through statistical means. Other important
empirical aspects affecting the computing of indices are the avail-
ability of information (national census, local databases, etc.); the
territorial extension of the index (i.e. computed for a nation or
smaller areas) and the geographic level at which they can be
computed (census tract, municipality, etc.). Finally, although
widely used in public health, deprivation indices are rarely
validated, except in few mainly British and Italian studies.54,57,59–63
Validating a deprivation index means verifying whether it adequately
reflects the reality being measured and this is possible, for instance,
by comparison with other synthetic indicators that, at the same
geographic level, describe specific aspects of the deprivation
concept and for which the direction of the relationship with depriv-
ation is well-known.59
All these considerations about deprivation indices should be
considered among the limits of our review. Other limitations are
represented by the inclusion of only published studies, which means
that publication bias cannot be ruled out. Furthermore, we did not
search in the grey literature and, as only studies written in English or
Italian were considered, we may have missed some relevant studies
published in other languages. Most of the included studies were
cross-sectional survey, which can be considered as a limitation,
although the information on vaccine uptake was obtained in most
cases from national/regional registries and database or at least
validated by crossing with patients’ electronic health records.
Another critical point is that the raw data were not available even
after contacting the principal investigator and that groups being
compared were defined according to different indices and cut-offs.
Further, we did not investigate reasons for not accepting the vaccine;
however, this was not the purpose of this study. A meta-analysis was
not performed due to the heterogeneity in considered indices and
compared groups. Nonetheless, results from multivariate analyses
were shown in tables since they provided a more comprehensive
and robust overview of results. In addition, our findings might
not be generalizable to other populations from middle and low-
income countries, since most of the included studies were
conducted in high-income countries, which makes challenging the
translation of the evidence into other health-care systems.
Our study also has several strengths. The thoroughness of the
search strategy, the double-blind evaluation, the focus on different
risk groups and the attempt to provide a comprehensive synthesis of
the available evidence are definitely strengths of this study. The
search, in fact, covered a wide time interval, including studies that
evaluated different influenza seasons and both pandemic and
seasonal influenza vaccination. In addition, influenza vaccination
policies and the composition of deprivation indices/SES were
explained in detail in most of the included studies. This aspect
allowed us to have a good insight into the complex relationship
between socio-economic and deprivation status and influenza
vaccine uptake in different risk groups and across different
countries/regions.
In conclusion, this systematic review, to the best of our knowledge,
is the first that, through a systematic and thorough approach, focussed
on the relationship between influenza vaccination uptake and depriv-
ation and SES in populations where the influenza vaccination is rec-
ommended, highlighting the importance of strengthening
interventions tailored to the different population categories.
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